Come up with a name for your new list and we'll add to it:
Dezima Pharma was acquired by
Amgen on September 16, 2015.
Dezima Pharma develops drugs to treat dyslipidemia, a major modifiable risk for cardiovascular disease. Dezima's objective is to develop compounds from pre-clinical development to meaningful proof of …